Stefaan Van Gool MD. PhD.
Medical Director Translational Oncology
Tumour immunologist with specialisation in brain tumours
Stefaan Van Gool MD. PhD., is a specialist in paediatric haemato-oncology with a focus on brain tumours. From 2001 to 2004, he was Chief Clinical Investigator at the Scientific Research Fund Flanders. Between 2006 and 2016, he held a full professorship at the Faculty of Medicine of the Catholic University of Leuven. From 2012 to 2015, he was head of the Paediatric Immunology Laboratory. He is the author of nearly 200 scientific articles in international journals.
In recognition of his scientific achievements, he was awarded a number of honours:
1995 Schweisguth Prize of the International Society of Paediatric Oncology
1996 Nycomed Prize of the International Society of Paediatric Oncology
1998 Rik en Nel Wouters Foundation Prize for Cancer Research (with Ludwig Van den Hove)
From 2005 to 2009 he was the coordinator of the European Expert Group on High Grade Glioma
Since 2008, he has been a member of the Supreme Health Court in Belgium
1996 Nycomed Prize of the International Society of Paediatric Oncology
1998 Rik en Nel Wouters Foundation Prize for Cancer Research (with Ludwig Van den Hove)
From 2005 to 2009 he was the coordinator of the European Expert Group on High Grade Glioma
Since 2008, he has been a member of the Supreme Health Court in Belgium
From 2014 to 2017, he served as co-chair of the Brain Tumour Working Group of the European Society for Paediatric Oncology.
At the IOZK, he is the head of the medical team and is responsible for the planning and implementation of the IOZK immunotherapy. In drug manufacturing, he acts as a Qualified Person (GMP) and Responsible Medical Person.
“Since every tumour is different, the best results are achieved by targeting the unique tumour cell type with the patient’s own dendritic cells”
Stefaan Van Gool MD. PhD.
Compilation: Scientific contributions and international publications by Stefaan Van Gool MD. PhD
Further Information on This Topic:
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Cologne | Germany
T: +49 (0)221 – 420 399 25
F: +49(0)221 - 420 399 26
E-Mail: info@iozk.de
Stefaan van Gool appointed as editor of a special issue by the Journal of Molecular Sciences
/in Brain Tumors in Children, IOZK publications /by IOZKPoster presentation at the annual meeting of the Association for Cancer Immunotherapy
/in Glioblastoma, IOZK at conferences, IOZK publications, Publications /by IOZKSymposium and Training at the IOZK: Immunotherapy in Neuro-Oncology, Friday, September 6, 2019
/in IOZK announcements, IOZK at conferences /by IOZKIOZK presentation on the effects of multi-modal immunotherapy in a pontine glioma with the aid of liquid biopsy analysis
/in IOZK at conferences, Other announcements /by rootIOZK presentation by Stefaan Van Gool: Immunotherapy for diffuse intrinsic pontine glioma (DIPG), at the annual meeting of the Society for Neuro-Oncology (SNO) in San Francisco
/in IOZK announcements, IOZK at conferences /by IOZKIOZK publication in Austin Oncology Case Reports on anti-tumor vaccines
/in IOZK in the press, IOZK publications /by IOZKArticle on pediatric neuro-oncologist Stefaan Van Gool in the Washington Post
/in IOZK in the press /by IOZK